{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:18Z","timestamp":1792788498958,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82400259"],"award-info":[{"award-number":["82400259"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82293630"],"award-info":[{"award-number":["82293630"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82293632"],"award-info":[{"award-number":["82293632"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fundamental Research Funds for the Central Universities","award":["21625219"],"award-info":[{"award-number":["21625219"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["21623121"],"award-info":[{"award-number":["21623121"]}]},{"name":"Science and Technology Project in Guangzhou","award":["202102070001"],"award-info":[{"award-number":["202102070001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05141-y","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:15:38Z","timestamp":1782623738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of T cell exhaustion in hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"17","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"5141_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech SM, Cui W. Transcriptional control of effector and memory CD8\u2009+\u2009T cell differentiation. Nat Rev Immunol. 2012;12:749\u201361.","journal-title":"Nat Rev Immunol"},{"key":"5141_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","volume":"21","author":"M Reina-Campos","year":"2021","unstructured":"Reina-Campos M, Scharping NE, Goldrath AW. CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21:718\u201338.","journal-title":"Nat Rev Immunol"},{"key":"5141_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","volume":"30","author":"N Ohkura","year":"2020","unstructured":"Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 2020;30:465\u201374.","journal-title":"Cell Res"},{"key":"5141_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu Y, Ho P. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2:1001\u201312.","journal-title":"Nat Metab"},{"key":"5141_CR5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342\u201356.","journal-title":"Cell"},{"key":"5141_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbmt.2018.03.030","volume":"24","author":"L Liu","year":"2018","unstructured":"Liu L, Chang Y, Xu L, Zhang X, Wang Y, Liu K, et al. Reversal of T cell exhaustion by the first donor lymphocyte infusion is associated with the persistently effective antileukemic responses in patients with relapsed AML after Allo-HSCT. Biol Blood Marrow Transplant. 2018;24:1350\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"5141_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.blre.2012.11.002","volume":"27","author":"Y Chang","year":"2013","unstructured":"Chang Y, Huang X. Donor lymphocyte infusions for relapse after allogeneic transplantation: when, if and for whom? Blood Rev. 2013;27:55\u201362.","journal-title":"Blood Rev"},{"key":"5141_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2025.101629","volume":"38","author":"TR Spitzer","year":"2025","unstructured":"Spitzer TR, Lazarus HM, Gale RP. Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface. Best Pract Res Clin Haematol. 2025;38:101629.","journal-title":"Best Pract Res Clin Haematol"},{"key":"5141_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"A Globig","year":"2023","unstructured":"Globig A, Zhao S, Roginsky J, Maltez VI, Guiza J, Avina-Ochoa N, et al. The \u03b2(1)-adrenergic receptor links sympathetic nerves to T?cell exhaustion. Nature. 2023;622:383\u201392.","journal-title":"Nature"},{"key":"5141_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36:265\u201376.","journal-title":"Trends Immunol"},{"key":"5141_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/imm.13642","volume":"169","author":"X Yin","year":"2023","unstructured":"Yin X, He L, Guo Z. T-cell exhaustion in CAR-T-cell therapy and strategies to overcome it. Immunology. 2023;169:400\u201311.","journal-title":"Immunology"},{"key":"5141_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood.2023019875","volume":"142","author":"H Senjo","year":"2023","unstructured":"Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, et al. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023;142:477\u201392.","journal-title":"Blood"},{"key":"5141_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13287-025-04321-6","volume":"16","author":"Q Xu","year":"2025","unstructured":"Xu Q, Wang R, Sui K, Xu Y, Zhou Y, He Y, et al. Enhance the therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in prevention of acute graft-versus-host disease through CRISPLD2 modulation. Stem Cell Res Ther. 2025;16:222.","journal-title":"Stem Cell Res Ther"},{"key":"5141_CR14","doi-asserted-by":"publisher","first-page":"eadf8366","DOI":"10.1126\/scitranslmed.adf8366","volume":"15","author":"M Prado-Acosta","year":"2023","unstructured":"Prado-Acosta M, Jeong S, Utrero-Rico A, Goncharov T, Webster JD, Holler E, et al. Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects. Sci Transl Med. 2023;15:eadf8366.","journal-title":"Sci Transl Med"},{"key":"5141_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","volume":"10","author":"M Noviello","year":"2019","unstructured":"Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, et al. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT. Nat Commun. 2019;10:1065.","journal-title":"Nat Commun"},{"key":"5141_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto M, Kamphorst AO, Im SJ, Kissick HT, Pillai RN, Ramalingam SS, et al. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. Annu Rev Med. 2018;69:301\u201318.","journal-title":"Annu Rev Med"},{"key":"5141_CR17","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205\u201313.","journal-title":"J Exp Med"},{"key":"5141_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.trecan.2022.04.004","volume":"8","author":"CC Zebley","year":"2022","unstructured":"Zebley CC, Youngblood B. Mechanisms of T cell exhaustion guiding next-generation immunotherapy. Trends Cancer. 2022;8:726\u201334.","journal-title":"Trends Cancer"},{"key":"5141_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining \u2018T cell exhaustion\u2019. Nat Rev Immunol. 2019;19:665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"5141_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399.","journal-title":"Nat Rev Immunol"},{"key":"5141_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"5141_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439:682\u20137.","journal-title":"Nature"},{"key":"5141_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity. 2016;44:989\u20131004.","journal-title":"Immunity"},{"key":"5141_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41577-023-00867-9","volume":"23","author":"K Chamoto","year":"2023","unstructured":"Chamoto K, Yaguchi T, Tajima M, Honjo T. Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1. Nat Rev Immunol. 2023;23:682\u201395.","journal-title":"Nat Rev Immunol"},{"key":"5141_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai L, Li Y, Tan J, Xu L, Li Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J Hematol Oncol. 2023;16:101.","journal-title":"J Hematol Oncol"},{"key":"5141_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","volume":"24","author":"V Aggarwal","year":"2023","unstructured":"Aggarwal V, Workman CJ, Vignali DAA. LAG-3 as the third checkpoint inhibitor. Nat Immunol. 2023;24:1415\u201322.","journal-title":"Nat Immunol"},{"key":"5141_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332:600\u20133.","journal-title":"Science"},{"key":"5141_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014;26:923\u201337.","journal-title":"Cancer Cell"},{"key":"5141_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N Watanabe","year":"2003","unstructured":"Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol. 2003;4:670\u20139.","journal-title":"Nat Immunol"},{"key":"5141_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-025-02327-3","volume":"11","author":"Y Wu","year":"2026","unstructured":"Wu Y, Wu Y, Gao Z, Yu W, Zhang L, Zhou F. Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion. Signal Transduct Target Ther. 2026;11:2.","journal-title":"Signal Transduct Target Ther"},{"key":"5141_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trecan.2022.12.008","volume":"9","author":"MB Watowich","year":"2023","unstructured":"Watowich MB, Gilbert MR, Larion M. T cell exhaustion in malignant gliomas. Trends Cancer. 2023;9:270\u201392.","journal-title":"Trends Cancer"},{"key":"5141_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch B, Johnson AL, Kurachi M, Odorizzi PM, Pauken KE, Attanasio J, et al. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. Immunity. 2016;45:358\u201373.","journal-title":"Immunity"},{"key":"5141_CR33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","volume":"16","author":"A Schurich","year":"2016","unstructured":"Schurich A, Pallett LJ, Jajbhay D, Wijngaarden J, Otano I, Gill US, et al. Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8+ T Cells in the Same Host. Cell Rep. 2016;16:1243\u201352.","journal-title":"Cell Rep"},{"key":"5141_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol. 2021;22:205\u201315.","journal-title":"Nat Immunol"},{"key":"5141_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cmet.2020.11.004","volume":"32","author":"W Li","year":"2020","unstructured":"Li W, Cheng H, Li G, Zhang L. Mitochondrial damage and the road to exhaustion. Cell Metab. 2020;32:905\u20137.","journal-title":"Cell Metab"},{"key":"5141_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12967-025-06833-4","volume":"23","author":"B Wang","year":"2025","unstructured":"Wang B, Tang J, Zhou Y, Huang Q, Jiang X, Zhang F, et al. Abnormal metabolic activation of CD8(+) T cells correlates with poor prognosis in acute myeloid leukemia. J Transl Med. 2025;23:791.","journal-title":"J Transl Med"},{"key":"5141_CR37","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Kn Pper K, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun. 2023;14:6858.","journal-title":"Nat Commun"},{"issue":"1","key":"5141_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12943-025-02407-6","volume":"24","author":"Y Lv","year":"2025","unstructured":"Lv Y, Li Z, Liu S, Zhou Z, Song J, Ba Y, et al. Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy. Mol Cancer. 2025;24:210.","journal-title":"Mol Cancer"},{"key":"5141_CR39","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ymthe.2024.04.004","volume":"32","author":"T Ahn","year":"2024","unstructured":"Ahn T, Bae E, Seo H. Decoding and overcoming T cell exhaustion: epigenetic and transcriptional dynamics in CAR-T cells against solid tumors. Mol Ther. 2024;32:1617\u201327.","journal-title":"Mol Ther"},{"key":"5141_CR40","doi-asserted-by":"publisher","first-page":"eadg1094","DOI":"10.1126\/sciimmunol.adg1094","volume":"9","author":"SA Minnie","year":"2024","unstructured":"Minnie SA, Waltner OG, Zhang P, Takahashi S, Nemychenkov NS, Ensbey KS, et al. TIM-3(+) CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Sci Immunol. 2024;9:eadg1094.","journal-title":"Sci Immunol"},{"key":"5141_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"J Beltra","year":"2020","unstructured":"Beltra J, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, et al. Developmental Relationships of Four Exhausted CD8(+) T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity. 2020;52:825\u201341.","journal-title":"Immunity"},{"key":"5141_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165673","volume":"133","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Dong L, Chang Y, Zhang X, Wang C, et al. Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8\u2009+\u2009progenitor exhausted T cell expansion in tumor models. J Clin Invest. 2023;133:e165673.","journal-title":"J Clin Invest"},{"key":"5141_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04126-z","volume":"16","author":"AA Aljagthmi","year":"2025","unstructured":"Aljagthmi AA, Abdel-Aziz AK. Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation. Stem Cell Res Ther. 2025;16:60.","journal-title":"Stem Cell Res Ther"},{"key":"5141_CR44","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1097\/BS9.0000000000000261","volume":"7","author":"W Dai","year":"2025","unstructured":"Dai W, Dong F, Cheng T, Hao S. T Cell immune reconstitution after allo-HSCT: key factors and implications. Blood Sci. 2025;7:e261.","journal-title":"Blood Sci"},{"key":"5141_CR45","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3324\/haematol.2019.216101","volume":"104","author":"P Merli","year":"2019","unstructured":"Merli P, Caruana I, De Vito R, Strocchio L, Weber G, Del Bufalo F, et al. Role of interferon-\u03b3 in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019;104:2314\u201323.","journal-title":"Haematologica"},{"key":"5141_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg8014","volume":"9","author":"F Manfredi","year":"2023","unstructured":"Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, et al. Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. Sci Adv. 2023;9:eadg8014.","journal-title":"Sci Adv"},{"key":"5141_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03061","volume":"9","author":"K Cassady","year":"2018","unstructured":"Cassady K, Martin PJ, Zeng D. Regulation of GVHD and GVL Activity Via PD-L1 Interaction With PD-1 and CD80. Front Immunol. 2018;9:3061.","journal-title":"Front Immunol"},{"key":"5141_CR48","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1172\/JCI85796","volume":"126","author":"A Saha","year":"2016","unstructured":"Saha A, O\u2019Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642\u201360.","journal-title":"J Clin Invest"},{"key":"5141_CR49","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1182\/bloodadvances.2023009721","volume":"7","author":"M Miyata","year":"2023","unstructured":"Miyata M, Matsuki E, Ichikawa K, Takehara T, Hosokawa Y, Sekiguchi E, et al. Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation. Blood Adv. 2023;7:6936\u201348.","journal-title":"Blood Adv"},{"key":"5141_CR50","doi-asserted-by":"publisher","first-page":"112250","DOI":"10.1016\/j.celrep.2023.112250","volume":"42","author":"H Mohammadpour","year":"2023","unstructured":"Mohammadpour H, Tsuji T, MacDonald CR, Sarow JL, Rosenheck H, Daneshmandi S, et al. Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation. Cell Rep. 2023;42:112250.","journal-title":"Cell Rep"},{"key":"5141_CR51","doi-asserted-by":"publisher","first-page":"e165723","DOI":"10.1172\/JCI165723","volume":"133","author":"Q Li","year":"2023","unstructured":"Li Q, Wang X, Song Q, Yang S, Wu X, Yang D, et al. Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity. J Clin Invest. 2023;133:e165723.","journal-title":"J Clin Invest"},{"key":"5141_CR52","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.7150\/thno.105069","volume":"15","author":"JK Choi","year":"2025","unstructured":"Choi JK, Mbanefo EC, Yadav MK, Alhakeem SA, Nagarajan V, Nunes NS, et al. Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1\/LAG-3 checkpoint proteins. Theranostics. 2025;15:3610\u201326.","journal-title":"Theranostics"},{"key":"5141_CR53","doi-asserted-by":"publisher","first-page":"eabo3420","DOI":"10.1126\/sciimmunol.abo3420","volume":"7","author":"SA Minnie","year":"2022","unstructured":"Minnie SA, Waltner OG, Ensbey KS, Nemychenkov NS, Schmidt CR, Bhise SS, et al. Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity. Sci Immunol. 2022;7:eabo3420.","journal-title":"Sci Immunol"},{"key":"5141_CR54","doi-asserted-by":"publisher","first-page":"e170125","DOI":"10.1172\/JCI170125","volume":"134","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ullah MA, Waltner OG, Bhise SS, Ensbey KS, Schmidt CR, et al. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD. J Clin Invest. 2024;134:e170125.","journal-title":"J Clin Invest"},{"key":"5141_CR55","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1042\/CS20257272","volume":"139","author":"C Sligar","year":"2025","unstructured":"Sligar C, Jacobs MJ, Elhage A, Sluyter R, Watson D. Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1\u2009+\u2009T cell subsets. Clin Sci. 2025;139:1261\u201385.","journal-title":"Clin Sci"},{"key":"5141_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.immuni.2023.01.003","volume":"56","author":"F Sacirbegovic","year":"2023","unstructured":"Sacirbegovic F, G\u00fcnther M, Greco A, Zhao D, Wang X, Zhou M, et al. Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. Immunity. 2023;56:369\u201385.","journal-title":"Immunity"},{"key":"5141_CR57","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1172\/JCI91138","volume":"127","author":"X Ni","year":"2017","unstructured":"Ni X, Song Q, Cassady K, Deng R, Jin H, Zhang M, et al. PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8\u2009+\u2009T cells. J Clin Invest. 2017;127:1960\u201377.","journal-title":"J Clin Invest"},{"key":"5141_CR58","doi-asserted-by":"publisher","first-page":"e181568","DOI":"10.1172\/jci.insight.181568","volume":"10","author":"K Quann","year":"2025","unstructured":"Quann K, Sacirbegovic F, Rosenberger S, McFerran ER, Codispot KC, Garcia-Dieguez L, et al. The role of TCF-1\u2009+\u2009CD8+ exhausted progenitors and TCF-1 in graft-versus-host responses. JCI Insight. 2025;10:e181568.","journal-title":"JCI Insight"},{"key":"5141_CR59","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3389\/fimmu.2019.01034","volume":"10","author":"F Simonetta","year":"2019","unstructured":"Simonetta F, Pradier A, Bosshard C, Masouridi-Levrat S, Dantin C, Koutsi A, et al. Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2019;10:1034.","journal-title":"Front Immunol"},{"key":"5141_CR60","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1182\/bloodadvances.2024015200","volume":"9","author":"JM Magenau","year":"2025","unstructured":"Magenau JM, Frame DG, Riwes M, Maciejewski J, Anand S, Pawarode A, et al. PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome. Blood Adv. 2025;9:3878\u201386.","journal-title":"Blood Adv"},{"key":"5141_CR61","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ymthe.2025.11.019","volume":"34","author":"Y Tian","year":"2026","unstructured":"Tian Y, Jia B, Lee CY, Huang Q, Zhao C, Abraham C, et al. Engineered suppressor T cells overexpressing IFN-\u03b1 and PD-L1 inhibit GVHD but retain GVL effects in mice. Mol Ther. 2026;34:898\u2013915.","journal-title":"Mol Ther"},{"key":"5141_CR62","doi-asserted-by":"publisher","first-page":"e11890","DOI":"10.1136\/jitc-2025-011890","volume":"13","author":"Z Li","year":"2025","unstructured":"Li Z, Liu N, Shah Z, Jin L, Tian L, Sun X, et al. Comparative efficacy and safety of PSCA CAR-engineered V\u03b41 \u03b3\u03b4 T cells for immunotherapy of pancreatic cancer. J Immunother Cancer. 2025;13:e11890.","journal-title":"J Immunother Cancer"},{"key":"5141_CR63","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/cells13181545","volume":"13","author":"Q Guan","year":"2024","unstructured":"Guan Q, Gilpin SG, Doerksen J, Bath L, Lam T, Li Y, et al. The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts. Cells. 2024;13:1545.","journal-title":"Cells"},{"key":"5141_CR64","doi-asserted-by":"publisher","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","volume":"6","author":"B Bengsch","year":"2010","unstructured":"Bengsch B, Seigel B, Ruhl M, Timm JR, Kuntz M, Blum HE, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8\u2009+\u2009T cells is linked to antigen recognition and T cell differentiation. Plos Pathog. 2010;6:e1000947.","journal-title":"Plos Pathog"},{"key":"5141_CR65","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1182\/blood-2010-11-317297","volume":"117","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Price DA, Casazza JP, Ferrari G, Nason M, Chattopadhyay PK, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8\u2009+\u2009T-cell exhaustion in HIV infection. Blood. 2011;117:4805\u201315.","journal-title":"Blood"},{"key":"5141_CR66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u20139.","journal-title":"Nat Immunol"},{"key":"5141_CR67","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","volume":"18","author":"M Rha","year":"2021","unstructured":"Rha M, Shin E. Activation or exhaustion of CD8(+) T cells in patients with COVID-19. Cell Mol Immunol. 2021;18:2325\u201333.","journal-title":"Cell Mol Immunol"},{"key":"5141_CR68","doi-asserted-by":"publisher","first-page":"e60186","DOI":"10.1371\/journal.pone.0060186","volume":"8","author":"JJ Hong","year":"2013","unstructured":"Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F. Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection. PLoS ONE. 2013;8:e60186.","journal-title":"PLoS ONE"},{"key":"5141_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002840","volume":"8","author":"Y Peretz","year":"2012","unstructured":"Peretz Y, He Z, Shi Y, Yassine-Diab B, Goulet J, Bordi R, et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. Plos Pathog. 2012;8:e1002840.","journal-title":"Plos Pathog"},{"key":"5141_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2018.02.009","volume":"190","author":"L Liu","year":"2018","unstructured":"Liu L, Chang Y, Xu L, Zhang X, Wang Y, Liu K, et al. T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation. Clin Immunol. 2018;190:32\u201340.","journal-title":"Clin Immunol"},{"key":"5141_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108093","volume":"100","author":"EV Batorov","year":"2021","unstructured":"Batorov EV, Aristova TA, Pronkina NV, Sergeevicheva VV, Sizikova SA, Ushakova GY, et al. Highly proliferative and functional PD-1(+) and TIM-3(+) T cells are transiently increased in multiple myeloma following autologous hematopoietic stem cell transplantation. Int Immunopharmacol. 2021;100:108093.","journal-title":"Int Immunopharmacol"},{"key":"5141_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq1693","volume":"14","author":"J Ruder","year":"2022","unstructured":"Ruder J, Docampo MJ, Rex J, Obahor S, Naghavian R, M\u00fcller AMS, et al. Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis. Sci Transl Med. 2022;14:eabq1693.","journal-title":"Sci Transl Med"},{"key":"5141_CR73","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jaci.2022.08.004","volume":"151","author":"R Labrosse","year":"2023","unstructured":"Labrosse R, Boufaied I, Bourdin BT, Gona S, Randolph HE, Logan BR, et al. Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. J Allergy Clin Immun. 2023;151:260\u201371.","journal-title":"J Allergy Clin Immun"},{"key":"5141_CR74","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-020-17991-y","volume":"11","author":"M Zhou","year":"2020","unstructured":"Zhou M, Sacirbegovic F, Zhao K, Rosenberger S, Shlomchik WD. T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect. Nat Commun. 2020;11:4227.","journal-title":"Nat Commun"},{"key":"5141_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-024-03726-z","volume":"15","author":"T Rostami","year":"2024","unstructured":"Rostami T, Rostami MR, Mirhosseini AH, Mohammadi S, Nikbakht M, Alemi H, et al. Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant? Stem Cell Res Ther. 2024;15:111.","journal-title":"Stem Cell Res Ther"},{"key":"5141_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40164-025-00697-6","volume":"14","author":"TTD Pham","year":"2025","unstructured":"Pham TTD, Choi S, Koh JS, Heo B, Lee S, Lee M, et al. Elevated TIM3 expression on bone marrow T cells drives immune dysfunction in early relapsed blood cancer after allogeneic hematopoietic stem cell transplantation. Exp Hematol Oncol. 2025;14:107.","journal-title":"Exp Hematol Oncol"},{"key":"5141_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40164-025-00680-1","volume":"14","author":"G Sun","year":"2025","unstructured":"Sun G, Chen X, Pan T, Song K, Xie H, Tu M, et al. Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial. Exp Hematol Oncol. 2025;14:90.","journal-title":"Exp Hematol Oncol"},{"key":"5141_CR78","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.bbmt.2015.03.012","volume":"21","author":"A Radujkovic","year":"2015","unstructured":"Radujkovic A, Guglielmi C, Bergantini S, Iacobelli S, van Biezen A, Milojkovic D, et al. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? Biol Blood Marrow Transplant. 2015;21:1230\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"5141_CR79","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41409-021-01515-3","volume":"57","author":"C Schmid","year":"2022","unstructured":"Schmid C, Labopin M, Schaap N, Veelken H, Brecht A, Stadler M, et al. Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia. Bone Marrow Transplant. 2022;57:215\u201323.","journal-title":"Bone Marrow Transplant"},{"key":"5141_CR80","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86:2041\u201350.","journal-title":"Blood"},{"key":"5141_CR81","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"C Schmid","year":"2007","unstructured":"Schmid C, Labopin M, Nagler A, Bornh\u00e4user M, Finke J, Fassas A, et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938\u201345.","journal-title":"J Clin Oncol"},{"key":"5141_CR82","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2013-08-523001","volume":"123","author":"P Bachireddy","year":"2014","unstructured":"Bachireddy P, Hainz U, Rooney M, Pozdnyakova O, Aldridge J, Zhang W, et al. Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood. 2014;123:1412\u201321.","journal-title":"Blood"},{"key":"5141_CR83","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1038\/bcj.2015.58","volume":"5","author":"Y Kong","year":"2015","unstructured":"Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Zhu L, et al. PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. Blood Cancer J. 2015;5:e330.","journal-title":"Blood Cancer J"},{"key":"5141_CR84","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2018-01-825240","volume":"132","author":"SA Minnie","year":"2018","unstructured":"Minnie SA, Kuns RD, Gartlan KH, Zhang P, Wilkinson AN, Samson L, et al. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade. Blood. 2018;132:1675\u201388.","journal-title":"Blood"},{"key":"5141_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-026-01783-w","volume":"19","author":"E Shumilov","year":"2026","unstructured":"Shumilov E, Ngoya M, Berning P, Devillier R, Forcade E, Schroeder T, et al. Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party. J Hematol Oncol. 2026;19:17.","journal-title":"J Hematol Oncol"},{"key":"5141_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40164-022-00286-x","volume":"11","author":"K Lv","year":"2022","unstructured":"Lv K, Hu B, Xu M, Wan L, Jin Z, Xu M, et al. IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity. Exp Hematol Oncol. 2022;11:34.","journal-title":"Exp Hematol Oncol"},{"key":"5141_CR87","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-022-01287-3","volume":"15","author":"C Zhao","year":"2022","unstructured":"Zhao C, Bartock M, Jia B, Shah N, Claxton DF, Wirk B, et al. Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant. J Hematol Oncol. 2022;15:64.","journal-title":"J Hematol Oncol"},{"key":"5141_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJMoa1601202","volume":"375","author":"MS Davids","year":"2016","unstructured":"Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, et al. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. New Engl J Med. 2016;375:143\u201353.","journal-title":"New Engl J Med"},{"key":"5141_CR89","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2017-01-761346","volume":"130","author":"BM Haverkos","year":"2017","unstructured":"Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, et al. PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD. Blood. 2017;130:221\u20138.","journal-title":"Blood"},{"key":"5141_CR90","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/bloodadvances.2025016709","volume":"9","author":"RM Shapiro","year":"2025","unstructured":"Shapiro RM, Soiffer RJ. Targeting PD-1 for HCT relapse: an immunologic knife\u2019s edge. Blood Adv. 2025;9:3907\u20138.","journal-title":"Blood Adv"},{"key":"5141_CR91","first-page":"e213","volume":"7","author":"X Chen","year":"2024","unstructured":"Chen X, Sun G, Zhu X. \u03b3\u03b4 T cells in hematological malignancies: mechanisms and therapeutic strategies. Blood Sci. 2024;7:e213.","journal-title":"Blood Sci"},{"key":"5141_CR92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1705585","volume":"39","author":"S Ganepola","year":"2007","unstructured":"Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, et al. Patients at high risk for CMV infection and disease show delayed CD8\u2009+\u2009T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39:293\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"5141_CR93","doi-asserted-by":"publisher","first-page":"1027593","DOI":"10.3389\/fimmu.2022.1027593","volume":"13","author":"X Luo","year":"2023","unstructured":"Luo X, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Front Immunol. 2023;13:1027593.","journal-title":"Front Immunol"},{"key":"5141_CR94","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1182\/blood-2002-05-1387","volume":"100","author":"E Ozdemir","year":"2002","unstructured":"Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8\u2009+\u2009T cells. Blood. 2002;100:3690\u20137.","journal-title":"Blood"},{"key":"5141_CR95","doi-asserted-by":"publisher","first-page":"110302","DOI":"10.1016\/j.clim.2024.110302","volume":"265","author":"K Kielsen","year":"2024","unstructured":"Kielsen K, Ller M, Pedersen DL, Nielsen AE, Ifversen CH, Ryder M. Cytomegalovirus infection is associated with thymic dysfunction and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Clin Immunol. 2024;265:110302.","journal-title":"Clin Immunol"},{"key":"5141_CR96","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","volume":"125","author":"Y Suessmuth","year":"2015","unstructured":"Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire. Blood. 2015;125:3835\u201350.","journal-title":"Blood"},{"key":"5141_CR97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cellimm.2014.02.007","volume":"288","author":"T Kato","year":"2014","unstructured":"Kato T, Nishida T, Ito Y, Murase M, Murata M, Naoe T. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation. Cell Immunol. 2014;288:53\u20139.","journal-title":"Cell Immunol"},{"key":"5141_CR98","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jix357","volume":"216","author":"X Pei","year":"2017","unstructured":"Pei X, Zhao X, Chang Y, Liu J, Xu L, Wang Y, et al. Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus. J Infect Dis. 2017;216:945\u201356.","journal-title":"J Infect Dis"},{"key":"5141_CR99","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbmt.2009.03.022","volume":"15","author":"GM Gallez-Hawkins","year":"2009","unstructured":"Gallez-Hawkins GM, Thao L, Palmer J, Dagis A, Li X, Franck AE, et al. Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15:872\u201380.","journal-title":"Biol Blood Marrow Transplant"},{"key":"5141_CR100","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1086\/503838","volume":"42","author":"NE Annels","year":"2006","unstructured":"Annels NE, Kalpoe JS, Bredius RGM, Claas EC, Kroes ACM, Hislop AD, et al. Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution. Clin Infect Dis. 2006;42:1743\u20138.","journal-title":"Clin Infect Dis"},{"key":"5141_CR101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10238-023-01270-3","volume":"24","author":"J Huang","year":"2024","unstructured":"Huang J, Pan Z, Wang L, Zhang Z, Huang J, Jiang C, et al. Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation. Clin Exp Med. 2024;24:22.","journal-title":"Clin Exp Med"},{"key":"5141_CR102","doi-asserted-by":"publisher","first-page":"620891","DOI":"10.3389\/fimmu.2020.620891","volume":"11","author":"J Zhou","year":"2021","unstructured":"Zhou J, Shi D, Wei R, Wang Y, Yan C, Zhang X, et al. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation. Front Immunol. 2021;11:620891.","journal-title":"Front Immunol"},{"key":"5141_CR103","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","volume":"140","author":"R Admiraal","year":"2017","unstructured":"Admiraal R, de Koning CCH, Lindemans CA, Bierings MB, Wensing AMJ, Versluys AB, et al. Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation. J Allergy Clin Immun. 2017;140:1643\u201350.","journal-title":"J Allergy Clin Immun"},{"key":"5141_CR104","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/bloodadvances.2017012724","volume":"2","author":"C de Koning","year":"2018","unstructured":"de Koning C, Admiraal R, Nierkens S, Boelens JJ. Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2018;2:428\u201332.","journal-title":"Blood Adv"},{"key":"5141_CR105","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1073\/pnas.1913776117","volume":"117","author":"HJ Elsaesser","year":"2020","unstructured":"Elsaesser HJ, Mohtashami M, Osokine I, Snell LM, Cunningham CR, Boukhaled GM, et al. Chronic virus infection drives CD8 T cell-mediated thymic destruction and impaired negative selection. Proc Natl Acad Sci U S A. 2020;117:5420\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5141_CR106","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-024-01557-2","volume":"17","author":"F Zhou","year":"2024","unstructured":"Zhou F, Du F, Wang Z, Xue M, Wu D, Chen S, et al. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 2024;17:34.","journal-title":"J Hematol Oncol"},{"key":"5141_CR107","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","volume":"20","author":"C Girmenia","year":"2014","unstructured":"Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, et al. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood and Marrow Transplant. 2014;20:872\u201380.","journal-title":"Biol Blood and Marrow Transplant"},{"key":"5141_CR108","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11046-017-0115-y","volume":"182","author":"MH Miceli","year":"2017","unstructured":"Miceli MH, Churay T, Braun T, Kauffman CA, Couriel DR. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. Mycopathologia. 2017;182:495\u2013504.","journal-title":"Mycopathologia"},{"key":"5141_CR109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177460","volume":"134","author":"N Talvard-Balland","year":"2024","unstructured":"Talvard-Balland N, Braun LM, Dixon KO, Zwick M, Engel H, Hartmann A, et al. Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice. J Clin Invest. 2024;134:e177460.","journal-title":"J Clin Invest"},{"key":"5141_CR110","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.4049\/jimmunol.2300111","volume":"211","author":"B Jia","year":"2023","unstructured":"Jia B, Zhao C, Minagawa K, Shike H, Claxton DF, Ehmann WC, et al. Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model. J Immunol. 2023;211:1426\u201337.","journal-title":"J Immunol"},{"key":"5141_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157907","volume":"133","author":"SA Minnie","year":"2023","unstructured":"Minnie SA, Waltner OG, Ensbey KS, Olver SD, Collinge AD, Sester DP, et al. TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice. J Clin Invest. 2023;133:e157907.","journal-title":"J Clin Invest"},{"key":"5141_CR112","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3324\/haematol.2022.282653","volume":"109","author":"A Thiolat","year":"2024","unstructured":"Thiolat A, Pilon C, Caudana P, Moatti A, To NH, Sedlik C, et al. Treg-targeted IL-2\/anti-IL-2 complex controls graft-versus-host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation. Haematologica. 2024;109:129\u201342.","journal-title":"Haematologica"},{"key":"5141_CR113","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1038\/s41467-025-60394-0","volume":"16","author":"F Mazziotta","year":"2025","unstructured":"Mazziotta F, Martin LE, Egan DN, Bar M, Kinsella S, Paulson KG, et al. A phase I\/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence. Nat Commun. 2025;16:5214.","journal-title":"Nat Commun"},{"key":"5141_CR114","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","volume":"124","author":"Y Taur","year":"2014","unstructured":"Taur Y, Jenq RR, Perales M, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174\u201382.","journal-title":"Blood"},{"key":"5141_CR115","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. New Engl J Med. 2020;382:822\u201334.","journal-title":"New Engl J Med"},{"key":"5141_CR116","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.chom.2023.06.009","volume":"31","author":"N Vallet","year":"2023","unstructured":"Vallet N, Salmona M, Malet-Villemagne J, Bredel M, Bondeelle L, Tournier S, et al. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses. Cell Host Microbe. 2023;31:1386\u2013403.","journal-title":"Cell Host Microbe"},{"key":"5141_CR117","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment. Cell Metab. 2019;30:143\u201356.","journal-title":"Cell Metab"},{"key":"5141_CR118","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1097\/BS9.0000000000000270","volume":"8","author":"M Walid","year":"2026","unstructured":"Walid M, Saboor M, Haque S, Mohammad MG. The tumor microenvironment in hematologic malignancies: immune evasion, metabolic reprogramming, and therapeutic resistance. Blood Sci. 2026;8:e270.","journal-title":"Blood Sci"},{"key":"5141_CR119","doi-asserted-by":"publisher","first-page":"114632","DOI":"10.1016\/j.celrep.2024.114632","volume":"43","author":"PM Gubser","year":"2024","unstructured":"Gubser PM, Wijesinghe S, Heyden L, Gabriel SS, de Souza DP, Hess C, et al. Aerobic glycolysis but not GLS1-dependent glutamine metabolism is critical for anti-tumor immunity and response to checkpoint inhibition. Cell Rep. 2024;43:114632.","journal-title":"Cell Rep"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05141-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:27:29Z","timestamp":1789532849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05141-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5141"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05141-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"315"}}